Eli Lilly lança Zepbound, seu novo tratamento para obesidade nos EUA

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Eli Lilly lança Zepbound, seu novo tratamento para obesidade nos EUA

/jornal/2023/12/eli-lilly-lanca-zepbound-seu-novo-tratamento-para-obesidade-nos-eua/

Lilly Drn (BOV:LILY34)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Lilly Drn Charts.

Lilly Drn (BOV:LILY34)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Lilly Drn Charts.

News

More News Articles

Revance Therapeutics

ProText Mobility (PK)

TransCode Therapeutics

Net Savings Link (PK)

Music Licensing (PK)

Nexus Energy Services (PK)

TideRock Companies (PK)

Globestar Therapeutics (PK)

Ronn Motor (PK)

Voip Pal Com (QB)

TPT Global Tech (CE)

Yuenglings Ice Cream (PK)

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions